Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Oncotarget|November 10, 2018
PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJAdam Harvey, Nicholas Mielke, Julia W Grimstead, et al.Plos Genetics|November 9, 2022
ATRX modulates the escape from a telomere crisisHelene E B Geiller, Adam Harvey, Rhiannon E Jones, et al.Hypertension (Dallas, Tex. : 1979)|August 17, 2016
Internal Pudental Artery Dysfunction in Diabetes Mellitus Is Mediated by NOX1-Derived ROS-, Nrf2-, and Rho Kinase-Dependent MechanismsRhéure Alves-Lopes, Karla B Neves, Augusto C Montezano, et al.Open Heart|June 10, 2020
Real-world insight into public access defibrillator use over five yearsHannah Torney, Olibhéar McAlister, Adam Harvey, et al.IEEE Journal of Translational Engineering in Health and Medicine|May 14, 2020
A Data-Driven Simulator for the Strategic Positioning of Aerial Ambulance Drones Reaching Out-of-Hospital Cardiac Arrests: A Genetic Algorithmic ApproachConor Mackle, Raymond Bond, Hannah Torney, et al.Therapeutic Advances in Gastroenterology|November 17, 2025
Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent Clostridioides difficile infection from five prospective clinical trials: an updateChristine Lee, Paul Feuerstadt, Thomas Louie, et al.JAMIA Open|July 31, 2025
Comparing artificial intelligence- vs clinician-authored summaries of simulated primary care electronic health recordsLara Shemtob, Abdullah Nouri, Adam Harvey-Sullivan, et al.Open Forum Infectious Diseases|August 11, 2023
Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical TrialKevin W Garey, Erik R Dubberke, Amy Guo, et al.BMC Infectious Diseases|March 13, 2022
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trialRobert Orenstein, Erik R Dubberke, Sahil Khanna, et al.BMJ Open|January 23, 2024
Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocolHugh Claridge, Claire A Price, Rofique Ali, et al.Pageof 5